Mice of the C3H/Sy (high incidence of spontaneous mammary cancer) and AKR/Sy (low incidence of spontaneous mammary cancer) inbred strains, which have different hormonal profiles, were injected daily with bromocriptine for 1 month. The treatment increased the duration of the ovarian cycle of the AKR/Sy mice, whereas that of the C3H/Sy mice was not affected. It is suggested that the effect of bromocriptine on the ovarian cycle depends on the concentrations of plasma progesterone reached in each strain of mouse.
BronsonH. F., DaggP. C. & SnellD. G. (1966). Reproduction. In Biology of the Laboratory Mouse (ed. GreenE. L.), 2nd edn, pp. 189-191. New York: McGraw-Hill.
2.
BrookesL. C. & WelshW. W. (1974). Reduction of serum prolactin in rats by 2 ergot alkaloids and 2 ergoline derivatives: a comparison. Proceedings of the Society for Experimental Biology and Medicine146, 863-867.
3.
CasselE. E., MeitesJ. & WelschW. C. L. (1971). Effects of ergocornine and ergocryptine on growth of 7,12-dimethylbenzanthracene-induced mammary tumors in rats. Cancer Research31, 1051-1053.
4.
FeketeE. (1953). A morphological study of the ovaries of virgin mice of eight inbred strains showing quantitative differences in their hormone producing components. Anatomical Record117, 93-113.
5.
FestingM. F. W. (1979). Inbred Strains in Biomedical Research, p. 148. London: Macmillan.
6.
MurphyE. D. (1966). Characteristic tumors. In Biology of the Laboratory Mouse (ed. GreenE. L.), 2nd edn, pp. 521-562. New York: McGraw-Hill.
7.
ParkesD. (1979). Drug therapy. Bromocryptine. New England Journal of Medicine301, 873-878.
8.
QuadriK. S. & MeitesJ. (1971). Regression of spontaneous mammary tumors in rats by ergot drugs. Proceedings of the Society for Experimental Biology and Medicine138, 999-1001.
9.
SinhaN. Y., SalacksB. C. & VanderlaanP. W. (1975). Prolactin and GH levels in different inbred strains of mice: patterns in association with estrogen cycle, time of day and perphenazine stimulation. Endocrinology97, 1112-1122.
10.
SinhaN. Y., SelbyW. F. & VanderlaanP. W. (1974). The natural history of prolacting and GH secretion in mice with high and low incidence of mammary tumors. Endocrinology94, 757-764.
11.
SymeonidisA. & LoustalotP. (1953). Uterine sensitivity to progresterone (deciduoma reaction) in mice of high and low mammary tumor incidence. Journal of the National Cancer Institute13, 851-855.
12.
Van der SchootP. & UilenbroekJ. Th. J. (1983). Reduction of 5-day cycle length of female rats by treatment with bromocryptine. Journal of Endocrinology97, 83-89.
13.
WelschW. C. & GriblerC. (1973). Prophylaxis of spontaneously developing mammary carcinoma in C3H/Hej female mice by suppression of prolactin. Cancer Research33, 2939-2946.
